Amid major restructuring, Novartis CEO Narasimhan’s 2022 pay fell by more than a quarter

Amid major restructuring, Novartis CEO Narasimhan’s 2022 pay fell by more than a quarter

Source: 
Fierce Pharma
snippet: 

Even as Novartis CEO Vas Narasimhan works through a companywide restructuring, the chief exec saw his pay decline substantially in 2022 thanks to demerits on the company’s shareholder return scorecard.